Search Results - "de Perosanz‐Lobo, D."

Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital by Fernandez‐Nieto, D., Ortega‐Quijano, D., Jimenez‐Cauhe, J., Burgos‐Blasco, P., Perosanz‐Lobo, D., Suarez‐Valle, A., Cortes‐Cuevas, J. L., Carretero, I., Garcia‐Del Real, C., Fernandez‐Guarino, M.

“…Summary COVID‐19 is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS‐CoV‐2). Vesicular skin rashes have been reported as associated…”
Get full text

Urticarial vasculitis in COVID‐19 infection: a vasculopathy‐related symptom? by de Perosanz‐Lobo, D., Fernandez‐Nieto, D., Burgos‐Blasco, P., Selda‐Enriquez, G., Carretero, I., Moreno, C., Fernández‐Guarino, M.

Get full text

Transient aquagenic syringeal acrokeratoderma during COVID‐19 outbreak: a retrospective case series of eight patients by Burgos‐Blasco, P., González‐Cañete, M., Melian‐Olivera, A., Vega‐Diez, D., Aldanondo‐Fernandez de la Mora, I., Perez‐Garcia, B., De Perosanz‐Lobo, D.

Get full text

Pulsed dye laser on ecchymoses: clinical and histological assessment by Alegre-Sánchez, Adrián, Saceda-Corralo, D., Segurado-Miravalles, G., de Perosanz-Lobo, D., Fonda-Pascual, P., Moreno-Arrones, O. M., Buendía-Castaño, D., Perez-García, B., Boixeda, P.

Get full text

Hepatotoxicity Associated With Vismodegib: Could Dose Reduction Be an Effective Management? by de Perosanz-Lobo, D., Burgos-Blasco, P., Moreno-Arrones, O.M., Bea-Ardebol, S.

Get full text

Interstitial Granulomatous Dermatitis and Tocilizumab: Is This Treatment Useful for This Skin Condition? by de Perosanz Lobo, D., Saceda Corralo, D., Ortega Quijano, D., Carrillo Gijón, R.

Get full text

Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association? by Alegre-Sánchez, A., de Perosanz-Lobo, D., Pinilla-Pagnon, I., Muñoz-Zato, E.

Get full text

Impact on Quality of Life in Dermatology Patients Attending an Emergency Department by Alegre-Sánchez, A, de Perosanz-Lobo, D, Pascual-Sánchez, A, Pindado-Ortega, C, Fonda-Pascual, P, Moreno-Arrones, Ó M, Jaén-Olasolo, P

“…Dermatological complaints have been estimated to represent up to 5-10% of all the visits to emergency departments. The main objective of our study was to…”
Get full text

Impact on Quality of Life in Dermatology Patients Attending an Emergency Department by Alegre-Sánchez, A., de Perosanz-Lobo, D., Pascual-Sánchez, A., Pindado-Ortega, C., Fonda-Pascual, P., Moreno-Arrones, Ó.M., Jaén-Olasolo, P.

“…[Display omitted] Dermatological complaints have been estimated to represent up to 5–10% of all the visits to emergency departments. The main objective of our…”
Get full text

Dermatitis granulomatosa intersticial y tocilizumab: ¿es este un tratamiento de utilidad para esta dermatosis? by de Perosanz Lobo, D., Saceda Corralo, D., Ortega Quijano, D., Carrillo Gijón, R.

Get full text

Interstitial Granulomatous Dermatitis and Tocilizumab: Is This Treatment Useful for This Skin Condition? by de Perosanz Lobo, D, Saceda Corralo, D, Ortega Quijano, D, Carrillo Gijón, R

Get full text

Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association? by Alegre-Sánchez, A, de Perosanz-Lobo, D, Pinilla-Pagnon, I, Muñoz-Zato, E

Get full text